XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Redeemable Convertible Preferred Stock
Common Stock [Member]
Class A and Class B common stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance at Dec. 31, 2020 $ (67,120)     $ 37,704 $ (104,824)
Beginning balance, Shares at Dec. 31, 2020     27,924,000    
Temporary equity, beginning balance, Shares at Dec. 31, 2020   61,717,000      
Temporary equity, beginning balance at Dec. 31, 2020   $ 187,811      
Stock-based compensation expense 2,628     2,628  
Exercise of stock options 1,488     1,488  
Exercise of stock options, Shares     1,226,000    
Vesting of early exercised stock options 179     179  
Net loss (6,439)       (6,439)
Ending balance at Mar. 31, 2021 (69,264)     41,999 (111,263)
Ending balance, Shares at Mar. 31, 2021     29,150,000    
Temporary equity, ending balance, Shares at Mar. 31, 2021   61,717,000      
Temporary equity, ending balance at Mar. 31, 2021   $ 187,811      
Beginning balance at Dec. 31, 2020 (67,120)     37,704 (104,824)
Beginning balance, Shares at Dec. 31, 2020     27,924,000    
Temporary equity, beginning balance, Shares at Dec. 31, 2020   61,717,000      
Temporary equity, beginning balance at Dec. 31, 2020   $ 187,811      
Net loss (16,522)        
Ending balance at Jun. 30, 2021 (65,689)     55,657 (121,346)
Ending balance, Shares at Jun. 30, 2021     31,910,000    
Temporary equity, ending balance, Shares at Jun. 30, 2021   67,136,000      
Temporary equity, ending balance at Jun. 30, 2021   $ 361,113      
Beginning balance at Mar. 31, 2021 (69,264)     41,999 (111,263)
Beginning balance, Shares at Mar. 31, 2021     29,150,000    
Temporary equity, beginning balance, Shares at Mar. 31, 2021   61,717,000      
Temporary equity, beginning balance at Mar. 31, 2021   $ 187,811      
Stock-based compensation expense 3,085     3,085  
Exercise of stock options 2,691     2,691  
Exercise of stock options, Shares     1,690,000    
Issuance of common stock under employee share purchase plan 7,402     7,402  
Vesting of early exercised stock options 480     480  
Issuance of redeemable convertible preferred stock, net of issuance costs   $ 173,302      
Temporary Equity Stock Issued During Period Shares New Issues   5,419,000      
Issuance of common stock in connection with an acquisition, Shares     1,070,000    
Net loss (10,083)       (10,083)
Ending balance at Jun. 30, 2021 (65,689)     55,657 (121,346)
Ending balance, Shares at Jun. 30, 2021     31,910,000    
Temporary equity, ending balance, Shares at Jun. 30, 2021   67,136,000      
Temporary equity, ending balance at Jun. 30, 2021   $ 361,113      
Beginning balance at Dec. 31, 2021 306,548   $ 1 486,354 (179,807)
Beginning balance, Shares at Dec. 31, 2021     109,876,000    
Stock-based compensation expense 13,785     13,785  
Exercise of stock options 3,977     3,977  
Exercise of stock options, Shares     1,603,000    
Vesting of restricted stock units, Shares     31,000    
Vesting of early exercised stock options 743     743  
Donation of common stock and repurchase of unvested stock options, Shares     (3,000)    
Cumulative impact of Topic 842 adoption 17       17
Net loss (22,220)       (22,220)
Ending balance at Mar. 31, 2022 302,849   $ 1 504,859 (202,011)
Ending balance, Shares at Mar. 31, 2022     111,507,000    
Beginning balance at Dec. 31, 2021 $ 306,548   $ 1 486,354 (179,807)
Beginning balance, Shares at Dec. 31, 2021     109,876,000    
Exercise of stock options, Shares 1,932,702        
Net loss $ (46,788)        
Ending balance at Jun. 30, 2022 298,054   $ 1 524,632 (226,579)
Ending balance, Shares at Jun. 30, 2022     112,294,000    
Beginning balance at Mar. 31, 2022 302,849   $ 1 504,859 (202,011)
Beginning balance, Shares at Mar. 31, 2022     111,507,000    
Stock-based compensation expense 15,155     15,155  
Exercise of stock options 1,176     1,176  
Exercise of stock options, Shares     329,000    
Issuance of common stock under employee share purchase plan 2,553     2,553  
Issuance of common stock under employee share purchase plan, Shares     176,000    
Vesting of restricted stock units, Shares     286,000    
Vesting of early exercised stock options 889     889  
Donation of common stock and repurchase of unvested stock options, Shares     (4,000)    
Net loss (24,568)       (24,568)
Ending balance at Jun. 30, 2022 $ 298,054   $ 1 $ 524,632 $ (226,579)
Ending balance, Shares at Jun. 30, 2022     112,294,000